To further elucidate the molecular interactions underlying the effect of isalpinin, we constructed a protein–protein interaction (PPI) network to identify central nodes and key pathways potentially modulated by isalpinin in NSCLC cells, and molecular docking studies were conducted focusing on AKT, a central regulator in cancer cell survival and proliferation. Here, AKT1 is linked to non-small cell lung carcinoma.